Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Using the Cecal Ligation and Puncture Model of Sepsis to Induce Rats to Multiple Organ Dysfunction

Texto completo
Autor(es):
Condor Capcha, Jose Manuel [1, 2] ; Moreira, Roberto S. [3] ; Rodrigues, Camila E. [1] ; Silveira, Marcelo A. D. [1] ; Andrade, Lucia [1] ; Gomes, Samirah A. [2]
Número total de Autores: 6
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Sch Med, Lab Basic Res, Sao Paulo - Brazil
[2] Univ Sao Paulo, Sch Med, Lab Genet Cellular Biol & Mol Biol, Sao Paulo - Brazil
[3] Fed Univ Catalao, Catalao - Brazil
Número total de Afiliações: 3
Tipo de documento: Artigo Científico
Fonte: BIO-PROTOCOL; v. 11, n. 7 APR 5 2021.
Citações Web of Science: 0
Resumo

Sepsis is a dysregulated hyperinflammatory disease caused by infection. Sepsis leads to multiple organ dysfunction syndrome (MODS), which is associated with high rates of mortality. The cecal ligation and puncture (CLP) model has been widely used in animals and has become the gold-standard method of replicating features of sepsis in humans. Despite several studies and modified CLP protocols, there are still open questions regarding the multifactorial determinants of its reproducibility and medical significance. In our protocol, which is also aimed at mimicking the sepsis observed in clinical practice, male Wistar rats are submitted to CLP with adequate fluid resuscitation (0.15 M NaCl, 25 ml/kg BW i.p.) immediately after surgery. At 6 h after CLP, additional fluid therapy (0.15 M NaCl, 25 ml/kg BW s.c.) and antibiotic therapy with imipenem-cilastatin (single dose of 14 mg/kg BW s.c.) are administered. The timing of the fluid and antibiotic therapy correspond to the initial care given when patients are admitted to the intensive care unit. This model of sepsis provides a useful platform for simulating human sepsis and could lay the groundwork for the development of new treatments. (AU)

Processo FAPESP: 15/21308-9 - Células-tronco mesenquimais derivados da geleia de Wharton na injuria cardiopulmonar e neuroimunomodulação sistêmica na sepse
Beneficiário:José Manuel Cóndor Capcha
Modalidade de apoio: Bolsas no Brasil - Doutorado
Processo FAPESP: 10/19012-0 - Avaliação da terapia com células-tronco hematopoiéticas na doença renal crônica em cães
Beneficiário:Lucia da Conceição Andrade
Modalidade de apoio: Auxílio à Pesquisa - Temático